The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
An Optimal Treatment for Pediatric Graves’ Disease Is Radioiodine
Abstract
Context: Antithyroid medications, surgery, and radioactive iodine have been used for more than five decades for the treatment of hyperthyroidism due to Graves’ disease in children, adolescents, and adults. Despite the widespread use of these different approaches, controversy still exists relative to the merits of each treatment, especially regarding the use of radioactive iodine. Objective: The objective of the study was to address the risk and benefits of 131I therapy, as compared with other treatment approaches. Position: Long-term, spontaneous remission of Graves’ disease occurs in less than 30% of children. Thus, the majority of children with Graves’ disease will need definitive, curative therapy. There is little evidence that use of antithyroid medications beyond 1 or 2 yr increases the likelihood of spontaneous, long-term remission. Although the use of antithyroid medications is standard practice, the use of antithyroid medications involves definite risks. When used at sufficient doses, radioactive iodine is an effective cure for Graves’ disease and is associated with few acute side effects. Potential long-term adverse side effects, including thyroid cancer and genetic damage, have yet to be observed in individuals treated as children or adolescents with 131I. Conclusion: Properly administered, radioactive iodine remains an ideal form of treatment for Graves’ disease in the pediatric population. Because of the increased risk of thyroid cancer associated with low-dose thyroid irradiation in children, larger, rather than smaller, doses of 131I should be given.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thyroid Cancer after Exposure to External Radiation: A Pooled Analysis of Seven Studies
Ron, E., Lubin, J. H., Shore, R. E., Mabuchi, K., Modan, B., Pottern, L. M., Schneider, A. B., Tucker, M. A., & Boice, J. D. (1995) · Radiation Research · doi:10.2307/3579003 · Cited by 1,107
Cooper, D. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmra042972 · Cited by 1,008
Relation between Therapy for Hyperthyroidism and the Course of Graves' Ophthalmopathy
Bartalena, L., Marcocci, C., Bogazzi, F., Manetti, L., Tanda, M. L., Dell'Unto, E., Bruno-Bossio, G., Nardi, M., Bartolomei, M. P., Lepri, A., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801083380201 · Cited by 715
DOBYNS, B. M., SHELINE, G. E., WORKMAN, J. B., TOMPKINS, E. A., McCONAHEY, W. M., & BECKER, D. V. (1974) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-38-6-976 · Cited by 391 · cited 9×
“The Cooperative Thyrotoxicosis Therapy Follow-up Study also showed that thyroid neoplasms developed in children treated with lower, rather than higher, doses of 131I. Thyroid adenomas developed in 30% of 30 children treated in one center with low doses of 131I estimated to result in thyroid exposure of 25 Gy ( 30 Ci/g…”
BackgroundResultInfluentialCancer Mortality Following Treatment for Adult Hyperthyroidism
Ron, E. (1998) · JAMA · doi:10.1001/jama.280.4.347 · Cited by 377
Management of Hyperthyroidism in Children and Adolescents
HAMBURGER, J. I. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-5-1019 · Cited by 161
Cancer mortality after iodine‐131 therapy for hyperthyroidism
Hall, P., Berg, G., Bjelkengren, G., Boice, J. D., Ericsson, U., Hallquist, A., Lidberg, M., Lundell, G., Tennvall, J., Wiklund, K., et al. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910500611 · Cited by 124
Predictors of Early Remission of Hyperthyroidism in Children1
Glaser, N. S., & Styne, D. M. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.6.3986 · Cited by 115
PETERS, H., FISCHER, C., BOGNER, U., REINERS, C., & SCHLEUSENER, H. (1996) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1996.98243.x · Cited by 74 · cited 1×
“When thyroid size exceeds 80 g, remission rates after (131)I therapy are poor (28).”
BackgroundThyroid Disease 60 Years After Hiroshima and 20 Years After Chernobyl
Boice, J. D. (2006) · JAMA · doi:10.1001/jama.295.9.1060 · Cited by 73
Time course to hypothyroidism after fixed-dose radioablation therapy of Graves' disease in children
Nebesio, T. D., Siddiqui, A. R., Pescovitz, O. H., & Eugster, E. A. (2002) · The Journal of Pediatrics · doi:10.1067/mpd.2002.125494 · Cited by 66
Toohey, R. E., Stabin, M. G., & Watson, E. E. (2000) · RadioGraphics · doi:10.1148/radiographics.20.2.g00mc33533 · Cited by 65
NICHOLAS, W. C., FISCHER, R. G., STEVENSON, R. A., & BASS, J. D. (1995) · Southern Medical Journal · doi:10.1097/00007611-199509000-00018 · Cited by 64
Complications of radioiodine treatment of hyperthyroidism
Becker, D. V., & Hurley, J. R. (1971) · Seminars in Nuclear Medicine · doi:10.1016/s0001-2998(71)81039-5 · Cited by 62
Treatment of childhood Graves' disease: A review with emphasis on radioiodine treatment
LEVY, W. J., SCHUMACHER, O. P., & GUPTA, M. (1988) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.55.4.373 · Cited by 60
Kadmon, P. M., Noto, R. B., Boney, C. M., Goodwin, G., & Gruppuso, P. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7473 · Cited by 58
Radiation and Thyroid Cancer: What More Can be Learned?
Boice Jr, J. D. (1998) · Acta Oncologica · doi:10.1080/028418698430520 · Cited by 28
Cited by
Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0229 · Cited by 2,938
“55 MBq/g) rather than smaller activities of RAI be administered to achieve hypothyroidism (312).”
BackgroundSelf-citationBahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., Rivkees, S. A., et al. (2011) · Endocrine Practice · doi:10.4158/ep.17.3.456 · Cited by 1,098
The American Thyroid Association and American Association of Clinical Endocrinologists Taskforce on Hyperthyroidism and Other Causes of Thyrotoxicosis, Bahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., et al. (2011) · Thyroid · doi:10.1089/thy.2010.0417 · Cited by 898
Self-citationBonnema, S. J., & Hegedüs, L. (2012) · Endocrine Reviews · doi:10.1210/er.2012-1030 · Cited by 339
Clinical and Economic Outcomes of Thyroid and Parathyroid Surgery in Children
Sosa, J. A., Tuggle, C. T., Wang, T. S., Thomas, D. C., Boudourakis, L., Rivkees, S., & Roman, S. A. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0660 · Cited by 329
Self-citation
Metadata
- Authors
- Rivkees, S. A., & Dinauer, C.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2007-03-01
- Volume
- 92
- Issue
- 3
- Pages
- 797-800
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2151740080
- Cited by
- 164
- References
- 17
- FWCI
- 7.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.